SYDNEY WILLIAMS: Open Payments
NPI 1104687995 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 1 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| CooperSurgical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: GRAFIX PL, MYFEMBREE, GEMTESA, SPRAVATO, Paragard T 380A, MOUNJARO, Mirena, Kerendia.
Industry payments across NE — which companies pay providers there.
